Position in NVS
as of Jun 30, 2026
· filed Jul 22, 2026
Position Value
$385,373
+$3,346 QoQ
Shares Held
2,459
-1.7% QoQ
Ownership
0.000%
of shares outstanding
% of Portfolio
0.12%
of 13F equity value
Holder Rank
#1,004
of 1,603 holders
Holding Since
Dec 2022
8 quarters on record
Voting authority
Sole 0%
Shared 0%
None 100%
Common Shares in NVS Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026DRIVE WEALTH MANAGEMENT, LLC holds $10,951,159 across 10 Drug Manufacturers - General names. NVS ranks #9 (3.5% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | LLY |
ELI LILLY & Co
|
3,080 | $3,694,244 | |
| 2 | ABBV |
AbbVie Inc.
|
6,804 | $1,712,158 | |
| 3 | MRK |
Merck & Co., Inc.
|
10,904 | $1,401,164 | |
| 4 | JNJ |
Johnson & Johnson
|
4,782 | $1,214,484 | |
| 5 | BMY |
Bristol Myers Squibb Co
|
14,082 | $811,404 | |
| 6 | GILD |
Gilead Sciences, Inc.
|
4,429 | $559,559 | |
| 7 | AMGN |
Amgen Inc
|
1,537 | $556,577 | |
| 8 | AZN |
Astrazeneca PLC
|
2,156 | $408,820 |
All Filings in NVS
Export CSV
8 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $385,373 | 2,459 | Shares | Sole | 2026-07-22 | |
| 2026-03-31 | $382,027 | 2,501 | Shares | Sole | 2026-04-14 | |
| 2025-12-31 | $342,054 | 2,481 | Shares | Other | 2026-02-04 | |
| 2023-12-31 | $231,625 | 2,294 | Shares | Sole | 2024-01-22 | |
| 2023-09-30 | $358,852 | 3,523 | Shares | Sole | 2023-10-11 | |
| 2023-06-30 | $446,728 | 4,427 | Shares | Sole | 2023-07-14 | |
| 2023-03-31 | $445,004 | 4,837 | Shares | Sole | 2023-04-13 | |
| 2022-12-31 | $479,455 | 5,285 | Shares | Sole | 2023-01-27 | |
| No filing history on record for this holder in this stock. | ||||||